These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9327719)

  • 21. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium.
    Soonpaa MH; Koh GY; Klug MG; Field LJ
    Science; 1994 Apr; 264(5155):98-101. PubMed ID: 8140423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow cells transdifferentiate to cardiomyocytes when introduced into the embryonic heart.
    Eisenberg CA; Burch JB; Eisenberg LM
    Stem Cells; 2006 May; 24(5):1236-45. PubMed ID: 16410395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypertrophic cardiomyopathy: functional effects of myosin mutation R723G in cardiomyocytes.
    Kraft T; Witjas-Paalberends ER; Boontje NM; Tripathi S; Brandis A; Montag J; Hodgkinson JL; Francino A; Navarro-Lopez F; Brenner B; Stienen GJ; van der Velden J
    J Mol Cell Cardiol; 2013 Apr; 57():13-22. PubMed ID: 23318932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and developmental properties of human embryonic stem cells-derived cardiomyocytes.
    Binah O; Dolnikov K; Sadan O; Shilkrut M; Zeevi-Levin N; Amit M; Danon A; Itskovitz-Eldor J
    J Electrocardiol; 2007; 40(6 Suppl):S192-6. PubMed ID: 17993321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventricular myocytes from failing human heart.
    Harding SE; Davies CH; Money-Kyrle AM; Poole-Wilson PA
    Cardiovasc Res; 1998 Dec; 40(3):523-9. PubMed ID: 10070493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular mechanisms in sympatho-modulation of the heart.
    Zaugg M; Schaub MC
    Br J Anaesth; 2004 Jul; 93(1):34-52. PubMed ID: 15145820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal myoblasts as a therapeutic agent.
    Menasché P
    Prog Cardiovasc Dis; 2007; 50(1):7-17. PubMed ID: 17631434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bone marrow--cardiac axis of myocardial regeneration.
    Liao R; Pfister O; Jain M; Mouquet F
    Prog Cardiovasc Dis; 2007; 50(1):18-30. PubMed ID: 17631435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium.
    Mewes T; Ravens U
    J Mol Cell Cardiol; 1994 Oct; 26(10):1307-20. PubMed ID: 7869391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microfilaments in cellular and developmental processes.
    Wessells NK; Spooner BS; Ash JF; Bradley MO; Luduena MA; Taylor EL; Wrenn JT; Yamada K
    Science; 1971 Jan; 171(3967):135-43. PubMed ID: 5538822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium.
    Lamberts RR; Hamdani N; Soekhoe TW; Boontje NM; Zaremba R; Walker LA; de Tombe PP; van der Velden J; Stienen GJ
    J Physiol; 2007 Jul; 582(Pt 2):695-709. PubMed ID: 17478529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiomyocytes structure, function and associated pathologies.
    Woodcock EA; Matkovich SJ
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1746-51. PubMed ID: 15950518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart muscle engineering: an update on cardiac muscle replacement therapy.
    Zimmermann WH; Didié M; Döker S; Melnychenko I; Naito H; Rogge C; Tiburcy M; Eschenhagen T
    Cardiovasc Res; 2006 Aug; 71(3):419-29. PubMed ID: 16697358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of calcium, inorganic phosphate, and pH on isometric force in single skinned cardiomyocytes from donor and failing human hearts.
    van Der Velden J; Klein LJ; Zaremba R; Boontje NM; Huybregts MA; Stooker W; Eijsman L; de Jong JW; Visser CA; Visser FC; Stienen GJ
    Circulation; 2001 Sep; 104(10):1140-6. PubMed ID: 11535570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle control in the terminally differentiated myocyte. A platform for myocardial repair?
    Williams RS
    Cardiol Clin; 1998 Nov; 16(4):739-54, x. PubMed ID: 9891601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiomyocytes of noncardiac origin in myocardial biopsies of human transplanted hearts.
    Müller P; Pfeiffer P; Koglin J; Schäfers HJ; Seeland U; Janzen I; Urbschat S; Böhm M
    Circulation; 2002 Jul; 106(1):31-5. PubMed ID: 12093766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of human myocardium in the rat heart from human embryonic stem cells.
    Laflamme MA; Gold J; Xu C; Hassanipour M; Rosler E; Police S; Muskheli V; Murry CE
    Am J Pathol; 2005 Sep; 167(3):663-71. PubMed ID: 16127147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological coupling of donor and host cardiomyocytes after cellular transplantation.
    Rubart M; Pasumarthi KB; Nakajima H; Soonpaa MH; Nakajima HO; Field LJ
    Circ Res; 2003 Jun; 92(11):1217-24. PubMed ID: 12730096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and cellular biology of the senescent hypertrophied and failing heart.
    Swynghedauw B; Besse S; Assayag P; Carré F; Chevalier B; Charlemagne D; Delcayre C; Hardouin S; Heymes C; Moalic JM
    Am J Cardiol; 1995 Nov; 76(13):2D-7D. PubMed ID: 7495213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac application of embryonic stem cells.
    Xiao YF
    Sheng Li Xue Bao; 2003 Oct; 55(5):493-504. PubMed ID: 14566394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.